RESEARCH · GLOBAL
Microsoft Research: RetroChimera accelerates chemical synthesis prediction at scale
Microsoft published Nature paper on RetroChimera, a predictive model that speeds molecular synthesis design. Reduces time/cost for custom-molecule discovery in pharma, materials, agriculture.
WHY IT MATTERS
Demonstrates AI acceleration of drug/molecule discovery; downstream impact on pharma BFSI (valuation models, R&D financing, biotech M&A due diligence). Banks should track synthetic-biology AI progress for sector trends.
Source: Microsoft Research · 2026-09-21